Continuous glucose monitoring (“CGM”) and annual PAD-Peripheral arterial disease screening are important for precise treatment decisions but unavailability of device and lack of expertise has led to underutilization of this technology. Our unique initiatives – Tendia CGM On Call and Tendia Vascular Screening have bridged this treatment gap & enabled thousands of patients with diabetes to receive continuous blood glucose monitoring with customized medication and diet plan. Tendia Glucometer Bank initiative aims at Self Glucose Monitoring (SGBM) for patients to use the device at home.
‘Insight’ is an initiative that enables clinicians and diagnosticians to diagnose early signs and symptoms of diabetic retinopathy. Insight is a comprehensive system which facilitates screening, diagnosis and interpretation of diabetic retinopathy which we believe is unaddressed due to the lack of relevant in-house facilities with most health care professionals treating diabetes